CDX2 expression rates were not significantly different according to sex, tumor location, histologic grade, pT stage, lymph node metastasis, venous, lymphatic, perineural invasion, and pTNM stage in the meta-regression test (Table 3). This evidence concerns the gene CDX2 and neoplasm.